EverPace Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2010

Location

Shanghai China

Primary Industry

Medical Devices & Equipment

About

Established in 2010 and based in Shanghai, China, EverPace is a cardiac electrophysiological interventional device developer, focusing on the development of innovative medical devices in the field of electrophysiological interventional diagnosis and ablation therapy. More than 160 patents have been granted to EverPace. In September 2019, the company received an Australian registration certificate for its body surface reference electrodes. Some certificates have been awarded to the company such as Shanghai Science and Technology Small Giant Enterprise, and Shanghai Specialized and New Small and Medium Enterprise. The products manufactured by the company can be categorized into three categories which are 3D systems, ablation catheters, and diagnostic catheters. Products within include Columbus® 3D cardiac electro-physiological marking system, OptimAblate® cardiac RF ablation device, FireMagic® 3D magnetically positioned cardiac RF ablation catheter, and EasyLoop® 3D single-use magnetically positioned annular marker catheter. Its products have served more than 700 hospitals.

Current Investors

Apricot Capital, Huaxing Growth Capital, CPE Funds Management

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Cardiology, Surgical Devices, Monitoring Equipment, Medical Equipment Distributors, Diagnostic Equipment

Website

www.ep.microport.com

Verticals

Manufacturing

Company Stage

Mature

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.